Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer. uri icon

authors

  • Yuan, Yuan
  • Martinez, Norma
  • Schmolze, Daniel
  • Presant, Cary
  • Ebrahimi, Behnam
  • Yeon, Christina
  • Mina S. Sedrak, MD, MS
  • Patel, Niki
  • Portnow, Jana
  • Lee, Peter
  • Mortimer, Joanne
  • Lee, Jin Sun
  • Yost, Susan E
  • Frankel, Paul H
  • Ruel, Christopher
  • Egelston, Colt A
  • Guo, Weihua
  • Padam, Simran
  • Tang, Aileen

publication date

  • January 1, 2021